Reason for request
Renouvellement d'inscription (CT)
Clinical Benefit
Moderate |
La Commission considère que le service médical rendu par PURIVIST 0,5 mg/ml, collyre en solution reste modéré dans l’indication de l’AMM.
|
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
CtPVQWVj4Qq0rkLR